Prudential plc’s Jazz Pharmaceuticals JAZZ Stock Holding History

Prudential plc’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,174	Closed	-$518K	–	789
2025 Q1	$518K	Buy	+4,174	New	+$545K	﹤0.01%	582
2024 Q1	–	Sell	-3,325	Closed	-$409K	–	820
2023 Q4	$409K	Buy	3,325 +6	+0.2%	+$749	﹤0.01%	805
2023 Q3	$430K	Sell	3,319 -28	-0.8%	-$3.73K	﹤0.01%	791
2023 Q2	$415K	Buy	+3,347	New	+$450K	﹤0.01%	814

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Prudential plc's JAZZ Position: Q2 2025 in Review

Prudential plc sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 4,174 shares — an estimated $518K sold.

Prudential plc first reported a position in JAZZ in Q2 2023 and held it in 4 quarters. The position peaked at $518K in Q1 2025. 501 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

Prudential plc reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Prudential plc sold 4,174 Jazz Pharmaceuticals shares in Q2 2025, an estimated $518K.
Prudential plc first reported a position in Jazz Pharmaceuticals in Q2 2023 and held it in 4 quarters.
Prudential plc's Jazz Pharmaceuticals position peaked at $518K in Q1 2025.
501 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Prudential plc's 13F filing for Q2 2025, filed 12 Aug 2025.